The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksByotrol Regulatory News (BYOT)

Share Price Information for Byotrol (BYOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10
Bid: 0.05
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.10 (200.00%)
Open: 0.125
High: 0.00
Low: 0.00
Prev. Close: 0.10
BYOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

24 Aug 2018 12:01

RNS Number : 8450Y
Byotrol PLC
24 August 2018
 

 

24 August 2018

 

 

 

 

 

Byotrol plc

("Byotrol", the "Company" or the "Group")

 

Director Dealing

 

 

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce that on 24 August 2018, Dr Trevor Francis, Chief Technical Officer of the Company purchased 657,686 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 3.8p per Ordinary Share (the "Purchase").

Following the Purchase, Mr. Francis has an interest in 2,910,902 Ordinary Shares representing approximately 0.68 per cent. of the total voting rights of the Company.

 

 

 

Enquiries:

 

 

Enquiries:

David Traynor - Chief Executive, Byotrol plc 01925 742 000

David Paton - Investor Relations 07714 190 474

 

 

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Tim Redfern/Richard Chambers - Corporate Broking

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

 

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

 

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk

 

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Francis

2.

Reason for the Notification

a)

Position/status

Chief Technical Officer

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 657,686

Price - 3.8 pence

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

24 August 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGZRGDVGRZM
Date   Source Headline
29th Nov 20112:35 pmRNSHolding(s) in Company
22nd Nov 20117:00 amRNSInterim Results
14th Nov 20114:40 pmRNSHolding(s) in Company
11th Nov 20119:46 amRNSHolding(s) in Company
9th Nov 20113:30 pmRNSHolding(s) in Company
7th Nov 201110:06 amRNSResult of EGM
21st Oct 20117:00 amRNSIssue of Equity to raise £2.46m
16th Sep 20117:00 amRNSChange of Adviser
21st Jul 20114:10 pmRNSResult of AGM
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil
28th Jun 20112:39 pmRNSAnnual Financial Report and AGM notice
27th Jun 201112:14 pmRNSHolding(s) in Company
24th Jun 201110:53 amRNSHolding(s) in Company
21st Jun 20117:00 amRNSPreliminary Results
11th May 20117:00 amRNSDevelopment Contract with Fortune 150 Company
7th Apr 20115:20 pmRNSHolding(s) in Company
8th Feb 20117:00 amRNSAgreement with McBride on European Licence
9th Dec 20107:00 amRNSLicence Agreement with makers of Tommee Tippee
30th Nov 20102:39 pmRNSDirector/PDMR Shareholding
16th Nov 20107:00 amRNSInterim Results
23rd Sep 20105:18 pmRNSHolding(s) in Company
3rd Sep 201010:12 amRNSHolding(s) in Company
31st Aug 201012:01 pmRNSResult of General Meeting
19th Aug 201012:50 pmRNSGrant of Options
11th Aug 20107:00 amRNSIssue of Equity
29th Jul 20103:33 pmRNSResult of AGM
7th Jul 20107:00 amRNSJDA in UK & Ireland and Agreement Extension in US
6th Jul 20102:18 pmRNSAnnual Report and Notice of AGM
30th Jun 20107:00 amRNSContract to supply Odour Elimination goods in USA
25th Jun 20103:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20104:02 pmRNSDirector/PDMR Shareholding
15th Jun 20107:00 amRNS2010 Preliminary Results
28th May 20107:00 amRNSResearch Grant, Patent Grant & Directorate Change
13th Apr 20101:38 pmRNSDirector/PDMR Shareholding
13th Apr 201010:16 amRNSDirector/PDMR Shareholding
30th Mar 20102:42 pmRNSDirector/PDMR Shareholding
25th Mar 201010:00 amRNSTrading update and results date
25th Mar 201010:00 amRNSDirectorate Change
26th Feb 201012:52 pmRNSTotal Voting Rights
4th Feb 20109:42 amRNSAcquisition of ByoFresh
22nd Dec 200911:40 amRNSHolding(s) in Company
22nd Dec 200911:40 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSUS Patent and Option Agreement
1st Dec 20097:00 amRNSSociety of Food Hygiene & Technology Award
20th Nov 20097:00 amRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim Results
6th Oct 20097:00 amRNSTrading Statement
29th Sep 200911:59 amRNSHolding(s) in Company
17th Sep 20097:00 amRNSTrading Statement
11th Aug 20099:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.